VACCINOPOLIS CENTER - Edegem, Belgium
Project Information
- Building Type:Health care
- Construction type: New
- Completion date: 2022
- Photos: ©Marcel van der Burg
Products
| COOL-LITE® SKN 183 | COOL-LITE® XTREME | ECLAZ® ZEN |
Description
Vaccinopolis, the new vaccine research centre for the University
of Antwerp and the Université Libre de Bruxelles, is playing a key role in the fight against current and future diseases. Research there is based on the CHIM principle, «Controlled Human Infection Model», i.e., vaccine testing on the basis of clinical trials. The research centre opened in March 2022 and, at 6,200 m2, is the largest of its kind in the European Union.Comparable CHIM studies have only previously been possible in the USA and Great Britain.
The single-storey narrow windows, window bands and a twostorey
atrium façade using both COOL-LITE® XTREME and COOL-LITE®
SKN 183 solar control coatings from Saint-Gobain Glass provide interiors that are bright and sun-protected as well as giving extended views. The south-facing window band around the patients’ rooms projects diagonally outwards from the façade plane. By using highly efficient solar control glass, optimal protection is provided against excessive solar heat gain, while also ensuring generous amounts of daylight.
Related products
COOL-LITE® SKN 183 & 183 II
With COOL-LITE® SKN 183 & SKN 183 II, architectural projects will benefit from the highest daylight income and most neutral look. They meet architects’ demand for truly neutral glass providing high daylight income indoors and good energetic performance for the building occupant's comfort.
ECLAZ® ZEN and ECLAZ® ZEN (II)
ECLAZ® ZEN (II) is the most transparent low-emissivity glass on the market within the category of best-in-class insulation products (Ug of 1.0 W/m²K in DGU).